HematologyImmunobiology of allogeneic stem cell transplantation and immunotherapy of hematological disease
Immunobiology of allogeneic stem cell transplantation and immunotherapy of hematological disease
BACKGROUND: After allogeneic hematopoietic stem-cell transplantation (HSCT), donor-derived T cells m...
Refractory or relapsed acute myeloid leukemia (AML) represents a frequent complication after allogen...
HematologyImmunobiology of allogeneic stem cell transplantation and immunotherapy of hematological d...
Under non-inflammatory conditions HLA class II is predominantly expressed on hematopoietic cells. Th...
Immunobiology of allogeneic stem cell transplantation and immunotherapy of hematological disease
After HLA class I-mismatched stem cell transplantation, allo-HLA–directed CD8 T cell responses can b...
Clinical studies demonstrated that HLA-DPB1 mismatched stem cell transplantation (SCT) is associated...
AbstractClinical studies have demonstrated that HLA-DPB1–mismatched allogeneic stem cell transplanta...
Allo-HLA reactive T-cells can mediate graft versus host disease (GVHD) after HLA mismatched stem cel...
Following HLA-DP-mismatched alloSCT and DLI, donor T cells show allogeneic (allo) HLA-DP-specific re...
Allogeneic (allo) stem cell transplantation is applied to patients suffering from hematologic malign...
Under non-inflammatory conditions HLA class II is predominantly expressed on hematopoietic cells. Th...
MHC alloantigen is recognized by two pathways: "directly," intact on donor cells, or "indirectly," a...
Immunobiology of allogeneic stem cell transplantation and immunotherapy of hematological disease
Immunobiology of allogeneic stem cell transplantation and immunotherapy of hematological disease
BACKGROUND: After allogeneic hematopoietic stem-cell transplantation (HSCT), donor-derived T cells m...
Refractory or relapsed acute myeloid leukemia (AML) represents a frequent complication after allogen...
HematologyImmunobiology of allogeneic stem cell transplantation and immunotherapy of hematological d...
Under non-inflammatory conditions HLA class II is predominantly expressed on hematopoietic cells. Th...
Immunobiology of allogeneic stem cell transplantation and immunotherapy of hematological disease
After HLA class I-mismatched stem cell transplantation, allo-HLA–directed CD8 T cell responses can b...
Clinical studies demonstrated that HLA-DPB1 mismatched stem cell transplantation (SCT) is associated...
AbstractClinical studies have demonstrated that HLA-DPB1–mismatched allogeneic stem cell transplanta...
Allo-HLA reactive T-cells can mediate graft versus host disease (GVHD) after HLA mismatched stem cel...
Following HLA-DP-mismatched alloSCT and DLI, donor T cells show allogeneic (allo) HLA-DP-specific re...
Allogeneic (allo) stem cell transplantation is applied to patients suffering from hematologic malign...
Under non-inflammatory conditions HLA class II is predominantly expressed on hematopoietic cells. Th...
MHC alloantigen is recognized by two pathways: "directly," intact on donor cells, or "indirectly," a...
Immunobiology of allogeneic stem cell transplantation and immunotherapy of hematological disease
Immunobiology of allogeneic stem cell transplantation and immunotherapy of hematological disease
BACKGROUND: After allogeneic hematopoietic stem-cell transplantation (HSCT), donor-derived T cells m...
Refractory or relapsed acute myeloid leukemia (AML) represents a frequent complication after allogen...